104
Views
21
CrossRef citations to date
0
Altmetric
Research Article

A 90-day intravenous administration toxicity study of CaO-SiO2-P2O5-B2O3 glass-ceramics (BGS-7) in rat

, , , &
Pages 38-47 | Received 07 Jul 2009, Accepted 23 Sep 2009, Published online: 08 Dec 2009
 

Abstract

CaO-SiO2-P2O5-B2O3 glass ceramics directly bond to bone and have potential use as a bone substitute material. The present study evaluated the toxicity from subchronic intravenous administration of CaO-SiO2-P2O5-B2O3 glass ceramics to male and female Sprague-Dawley rats. The rats were divided into four groups, each consisting of 10 male and 10 female rats, and administered different amounts of CaO-SiO2-P2O5-B2O3 glass ceramics (aqueous extract 5, 2.5, and 1.25 mL/kg body weight/day and saline) 7 days per week for 90 consecutive days. During the experiment, no deaths were observed in any groups, and there were no remarkable changes in clinical signs, body weight, food and water intake, hematological and serum biochemical parameters, organ weight, and histopathological findings between the control and treated groups. The results show no adverse toxic effects of CaO-SiO2-P2O5-B2O3 glass ceramics (aqueous extract 5 mL/kg body weight/day) to rats of either sex.

Acknowledgements

This work was supported by the Common Core Technology Development Program of the Korean Ministry of Knowledge and Economy (#A00-A01-3302-02-1-3). The authors would like to express their gratitude to the Clinical Research Institute of Seoul National University Hospital for executing animal tests and assessment and also to Bioalpha (Seongnam, Korea) for providing CaO-SiO2-P2O5-B2O3 glass-ceramics (BGS-7) used in this study.

Declaration of interest: All authors disclose here that there are no conflicts of interest that could inappropriately have influenced the outcome of the present study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.